In this special Third Thursdays Webinar, we discuss the most significant breakthrough to date in the search for a Parkinson’s biomarker: a highly accurate biological test for Parkinson’s disease. The test is capable of objectively and reliably detecting the disease at the molecular level — even before the onset of symptoms. The discovery, announced on April 12, will transform every aspect of drug development and ultimately clinical care.

Our panel of experts from MJFF and our landmark clinical study, the Parkinson’s Progression Markers Initiative, discuss the groundbreaking implications of the findings and answer questions from the audience.